Challenges and Changes: Kentucky’s Approach to Drug Treatment During COVID-19

Background: Kentucky’s Dual Crisis

By late 2020, Kentucky faced severe challenges. Under Governor Andy Beshear, the state aimed primarily to protect lives against two major issues: the COVID-19 pandemic and high rates of drug overdoses. Governor Beshear recognized addiction as a disease worsened by isolation, raising concerns that fear of COVID-19 could discourage people from seeking treatment.

In response, Kentucky joined over 40 states in easing Medicaid restrictions. This allowed recovery centers to offer costly treatments without needing prior approval from Medicaid insurers. By 2023, while most states restored prior approval requirements, Kentucky maintained its relaxed approach.

Record-Breaking Treatment Capacity

In 2023, Kentucky offered over 1,100 long-term treatment placements, more than any other state relative to its population. However, as Medicaid expenses increased, so did concerns over the quality of care. Warnings emerged about excessive billing by providers for substandard services.

Warnings and Concerns

By 2024, the Attorney General of Kentucky highlighted Medicaid fraud in drug treatment as a significant concern. Despite warnings, administrative actions to control the rising costs were limited. By early 2025, Medicaid spending on behavioral health and addiction treatment soared to $2.3 billion. Criticism pointed to unethical practices by some providers, including Addiction Recovery Care (ARC), the largest state-funded provider.

Investigations and Allegations

The FBI investigated ARC, leading to a $16 million settlement over Medicaid fraud claims. These arose from whistleblower accusations of fraudulent billing practices. Meanwhile, ARC faced allegations of wire fraud and money laundering against its leader, Tim Robinson, who pleaded not guilty.

Legislative and Political Ramifications

In 2025, a new law required insurers’ approval before treatment, reflecting Republican critiques of fraud and waste. Although Governor Beshear vetoed this legislation, citing potential healthcare delays, the legislature overrode his veto. Concurrently, calls for reinstating Medicaid’s prior authorization processes intensified.

Broader Implications and Trends

As overdose fatalities declined between 2020 and 2025, experts noted similar trends in other states, attributed to declining opioid prescriptions and naloxone use, rather than Medicaid policy changes. Critics argued that many treatments billed under Medicaid did not directly decrease overdose deaths.

Ongoing Challenges and Future Directions

ARC’s difficulties continued, leading to significant facility closures and reduced treatment slots statewide. By 2025, the organization struggled, and comprehensive billing investigations continued.

Conclusion: A Complex Landscape

Governor Beshear maintained his stance on prioritizing open access to treatment services through Medicaid, linking reduced overdose deaths to this policy. While acknowledging administrative delays, he argued that easing Medicaid restrictions was crucial in combating Kentucky’s addiction epidemic. Despite criticisms, Beshear remained focused on the broader impact: reducing addiction and potentially ending an epidemic in the state.